Thursday, December 23, 2010

It Works to Preserved Healthy Blood Sugar

The chemically treated term paper strips were manufactured at an Abbott facility in the United Kingdom between January and May 2010, according to company spokesman Scott Davies.

The deficiency came to light via routine in-house testing, Davies said.

Abbott, based in North Chicago, reported 22 cases of "false low" readings to the Food and Drug management and volunteered to accomplish the reminder, FDA spokeswoman Erica Jefferson said in an e-mail.

The agency is working with the company to conclude if there may be additional instances where the readings were inaccurate.

Though any inaccuracy in blood sugar readings is because for anxiety for diabetics, this is an error in a safer direction, falsely low rather than falsely high, said Michael Thompson, a diabetes researcher and associate professor of medicine at George Washington University.

A false high reading could guide the diabetics to overdose on insulin, triggering a dangerous hypoglycemic episode. This is not going to do that, Thompson said.

Abbott investigators have not strong-minded the source of the defect, but are looking at storage conditions as a possible cause. Strips showing to temperate weather or held in prolonged storage may be more likely to yield false results.

The bear in mind involves 359 lots of strips marketed by Alameda, Calif.-based Abbott Diabetes Care and are used with Abbott's Precision Extra, Precision Exceed Pro, Medicines Optimum, Optimum, Optimum EZ and Relizon Ultima blood glucose monitoring systems.

The monitors, which study blood sugar levels in blood collected in the strips, are not exaggerated by the recall, nor are other Abbott diabetes products. Consumers can still use well-matched test strips from lots with the intention of have not been recalled.


Post a Comment